^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Rhitol (allodepleted T-cell immunotherapeutics)

    i
    Associations
    News

    Trials

    Company:
    Sanofi
    Drug class:
    Immunomodulator, T lymphocyte replacement
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor (NCT02500550)
    Phase 2
    Kiadis Pharma
    Completed
    Last update posted :
    05/18/2021
    Initiation :
    10/09/2015
    Primary completion :
    07/01/2018
    Completion :
    12/17/2018
    HLA-B
    |
    Rhitol (allodepleted T-cell immunotherapeutics) • methylprednisolone sodium succinate